- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00448045
Preventing Pneumonia and Other Respiratory Problems in Persons With Spinal Cord Injury
Prevention of Long-Term Respiratory Complications of Spinal Cord Injury: a Randomized Controlled Trial
It is known that individuals with spinal cord injury are at increased risk for respiratory tract infections like pneumonia. Part of this risk is due to weakened chest and abdominal muscles that are vital to deep breathing and the ability to cough. The purpose of this study is to look at the effectiveness of two different treatments in preventing pneumonia and other respiratory problems in persons with SCI.
This is a randomized controlled trial investigating the effectiveness of two different treatments. Participants will be randomly assigned to one of the two treatment groups. They will not be told the details of the other intervention since this could influence or change their activities during the study.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Faza 2
Kontakty i lokalizacje
Lokalizacje studiów
-
-
New Jersey
-
West Orange, New Jersey, Stany Zjednoczone, 07052
- Kessler Institute for Rehabilitation
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Chronic spinal cord injury that occurred more than 6 months ago
- An impaired ability to cough (cough peak flow less than 300 L/min)
- Oxygen saturation greater than or equal to 95% when awake and not receiving supplemental oxygen
- End-tidal carbon dioxide level less than 43 mm Hg
- Without a fever or other signs of an acute illness for the previous 2 weeks
- Able to learn the treatment protocol and have someone available at home to assist if needed to help set-up and use the equipment
Exclusion Criteria:
- Under 18 years of age
- Currently have a tracheotomy tube
- Have a history of an acute illness in the last 2 weeks
- Have lung disease as seen on chest x-ray that results in a baseline oxygen saturation decreasing below 95% during daytime hours and cannot be normalized by usual way of coughing
- Already utilizing an oximetry protocol
- Have a significant medical complication and psychiatric condition that would interfere with the conduct of the study or interpretation of the study results.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Manual and mechanical assisted cough
Individuals will be given a pulse oximeter and taught both manually assisted and mechanically assisted coughing techniques to maximize their cough peak flow.
Manually assisted coughing consists of air stacking to deep insufflations.
An abdominal thrust is then applied upon glottic opening to augment the cough peak flow.
Subjects will also have rapid access to a mechanical in-exsufflator (CoughAssistTM) and will be trained on how to access and use this device.
Mechanically assisted coughing (MAC) involves the use of the CoughAssistTM to expand the lungs and then quickly reverse the pressure to rapidly empty the lungs with expiratory (cough) flows of 600 L/m.
An abdominal (manual) thrust is applied in conjunction with the negative pressure (exsufflation) to further increase cough.
|
Individuals will be given a pulse oximeter and taught both manually assisted and mechanically assisted coughing techniques to maximize their cough.
Manually assisted coughing consists of air stacking to deep insufflations.
An abdominal thrust is then applied upon glottic opening to augment the cough.
These subjects will also have rapid access to a mechanical in-exsufflator (CoughAssistTM) and will be trained on how to access and use this device.
Mechanically assisted coughing (MAC) involves the use of the CoughAssistTM to expand the lungs and then quickly reverse the pressure to rapidly empty the lungs with expiratory (cough) flows of 600 L/m.
An abdominal (manual) thrust is applied in conjunction with the negative pressure (exsufflation) to further increase cough.
Inne nazwy:
|
|
Aktywny komparator: Incentive spirometry
The active control group will consist of individuals assigned to the oximetry with incentive spirometry group.
These individuals will be given a pulse oximeter and an incentive spirometer (AirLife Company) and taught how to use them.
|
These individuals will be given a pulse oximeter and an incentive spirometer (AirLife Company) and taught how to use them.
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
|---|---|
|
Reductions in episodes of community acquired pneumonia (CAP) and related severe respiratory complications
Ramy czasowe: 3 years
|
3 years
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
|---|---|
|
Reductions in hospitalizations due to a primary diagnosis of a respiratory complications
Ramy czasowe: 3 years
|
3 years
|
|
Duration of illness and hospitalization
Ramy czasowe: 3 years
|
3 years
|
|
Impact of respiratory complications on quality of life and participation
Ramy czasowe: 3 years
|
3 years
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: John Bach, M.D., University of Medicine and Dentistry - The New Jersey Medical School, Newark, N.J.
- Główny śledczy: Steven Kirshblum, M.D., Kessler Institute for Rehabilitation, West Orange, N.J.
- Dyrektor Studium: Trevor A. Dyson-Hudson, M.D., Kessler Foundation
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- H133N060022
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .